Evaluation of PACE4 isoforms as biomarkers in thyroid cancer

BACKGROUND: To date, no single molecular marker has been demonstrated as clinically useful in differentiating malignant from benign thyroid nodules when a fine needle aspiration falls in the “unknown significance” categories of the Bethesda Classification. PACE4, a member of the proprotein convertas...

Descripción completa

Detalles Bibliográficos
Autores principales: Fradet, Laurent, Temmar, Rabia, Couture, Frédéric, Belzile, Mathieu, Fortier, Pierre-Hugues, Day, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194618/
https://www.ncbi.nlm.nih.gov/pubmed/30340539
http://dx.doi.org/10.1186/s40463-018-0311-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194618/
https://www.ncbi.nlm.nih.gov/pubmed/30340539
http://dx.doi.org/10.1186/s40463-018-0311-x

Ejemplares similares